| Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
|---|
| 09/25/1996 | EP0732943A1 Three-step pretargeting methods and compounds |
| 09/25/1996 | EP0732930A1 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |
| 09/25/1996 | EP0732924A1 Transdermal therapeutical system for preventing poisoning by organophosphoric nurotoxins that consists of a combination of active substances including a parasympathomimetic and a parasympatholytic agent |
| 09/25/1996 | EP0732923A1 Pharmaceutical compositions containing hiv protease inhibitors |
| 09/25/1996 | EP0732922A1 Transdermal delivery device |
| 09/25/1996 | EP0732915A1 Local delivery of fibrinolysis enhancing agents |
| 09/25/1996 | EP0732914A1 Sulfated polyvinyl alcohol polymers to stabilize pharmaceutical drug compounds |
| 09/25/1996 | EP0732913A1 Synthetic viscoelastic material for ophthalmic application |
| 09/25/1996 | EP0732912A1 Cosmetic and/or pharmaceutical preparations with improved skin feel |
| 09/25/1996 | EP0674507A4 Modified hydrolyzed vegetable protein microspheres and methods for preparation and use thereof. |
| 09/25/1996 | EP0650373B1 Sustained release alginate fibre and process for the preparation thereof |
| 09/25/1996 | EP0630233B1 Composition for oral preparations |
| 09/25/1996 | EP0497846B1 Drug delivery system, method for preparing the same, and use thereof |
| 09/25/1996 | CN1131675A Grosslinked acidic polysaccharides and their uses |
| 09/25/1996 | CN1131674A Glucagon insulinotropic complexes, compositions and methods |
| 09/25/1996 | CN1131539A Treatment of disease and conditions associated with macrophage infiltration |
| 09/25/1996 | CN1032841C Method for preparing antiacid effervescent couples |
| 09/24/1996 | USRE35338 Sustained release delivery of water soluble bio-molecules and drugs using phosphokipid-coated microcrystals, microdroplets and high-concentration lipsomes |
| 09/24/1996 | US5559214 Unsymmetrical complexing agents and targeting immunoreagents useful in thearpeutic and diagnostic compositions and methods |
| 09/24/1996 | US5559213 Polyethylene-protein conjugates |
| 09/24/1996 | US5559207 Texaphyrin metal complex mediated ester hydrolysis |
| 09/24/1996 | US5559157 Acetate, nicotinate or succinate, sorbic acid preservative |
| 09/24/1996 | US5559152 Pharmaceutical composition having antiacoholic activity |
| 09/24/1996 | US5559149 Skin care compositions containing retinoids |
| 09/24/1996 | US5559148 Parenteral busulfan for treatment of malignant disease |
| 09/24/1996 | US5559121 Rapamycin formulations for oral administration |
| 09/24/1996 | US5559098 Stable topical formulations with good active ingredient release characteristics, containing at least one lipophilized macrolide antibiotic |
| 09/24/1996 | US5558880 Matrix for drug delivery with amino acids and lyophilization or solid state dissolving |
| 09/24/1996 | US5558877 For vaginal insertion, silicone elastomer ring, tamoxifen |
| 09/24/1996 | US5558871 Vegetable oil |
| 09/24/1996 | US5558857 Contrast agents |
| 09/24/1996 | US5558633 Device and method for iontophoretic drug delivery |
| 09/24/1996 | US5558094 Introducing microbubbles of a biocompatible chemical into animal prior to imaging |
| 09/22/1996 | CA2172111A1 Nanosuspensions for intravenous administration |
| 09/22/1996 | CA2172110A1 Pharmaceutical carriers for nanosuspensions |
| 09/22/1996 | CA2150080A1 Glucagon-like insulinotropic complexes, compositions and methods |
| 09/19/1996 | WO1996028544A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells |
| 09/19/1996 | WO1996028475A1 Peg-modified hgf |
| 09/19/1996 | WO1996028244A1 Composition for stabilizing a suspension and pharmaceutical uses of said composition and of said suspension |
| 09/19/1996 | WO1996028188A2 Method of transmitting target-oriented substances |
| 09/19/1996 | WO1996028187A1 Method for treating amyloidosis |
| 09/19/1996 | WO1996028182A1 Method of preventing tpo adsorption and stable tpo-containing composition |
| 09/19/1996 | WO1996028181A1 Method of preventing tpo adsorption and stable tpo-containing composition |
| 09/19/1996 | WO1996028143A1 Polypeptide-containing pharmaceutical forms of administration in the form of microparticles and method for the preparation thereof |
| 09/19/1996 | WO1996028141A1 Improvements in or relating to organic compositions |
| 09/19/1996 | WO1996028133A1 Coolant compositions |
| 09/19/1996 | WO1996028090A1 A method of magnetic resonance focused surgical and therapeutic ultrasound |
| 09/19/1996 | WO1996028057A1 Conforming shoe construction using gels and method of making the same |
| 09/19/1996 | WO1996028029A1 Immunoisolation |
| 09/19/1996 | DE19509828A1 Oil-in-water emulsion for parenteral admin. contg. EDTA as antimicrobial agent |
| 09/19/1996 | CA2215315A1 Methods for preventing adsorption of thrombopoietin (tpo) and stable tpo-containing compositions |
| 09/19/1996 | CA2215249A1 Methods for preventing adsorption of thrombopoietin (tpo) and stable tpo-containing compositions |
| 09/19/1996 | CA2215039A1 Immunoisolation |
| 09/19/1996 | CA2214855A1 A method of magnetic resonance focused surgical and therapeutic ultrasound |
| 09/19/1996 | CA2214799A1 A protein-lipid conjugate, consisting of heparin binding protein (hbp) and a ceramide analogue, and its pharmaceutical use in treatment of conditions involving stress injury to cells |
| 09/19/1996 | CA2214108A1 Coolant compositions |
| 09/18/1996 | EP0732105A2 Affinity bound collagen matrices for the delivery of biologically active agents |
| 09/18/1996 | EP0732064A1 Bitterness-relieving agent |
| 09/18/1996 | EP0731812A1 POLY-beta-1-4-N-ACETYLGLUCOSAMINE |
| 09/18/1996 | EP0731807A1 N-2 substituted purines |
| 09/18/1996 | EP0731785A1 Ceramide 3 derivatives based on monounsaturated fatty acids |
| 09/18/1996 | EP0731705A1 Use of dimeticone for treating constipation |
| 09/18/1996 | EP0731696A1 Cysteine protease inhibitors containing heterocyclic leaving groups |
| 09/18/1996 | EP0731694A1 Opioid formulations for treating pain |
| 09/18/1996 | EP0731693A1 Microsphere drug delivery system |
| 09/18/1996 | EP0629244B1 Pathogen-targeted biocatalyst |
| 09/18/1996 | EP0588853B1 Polycarbonates and the use thereof for the preparation of bioerosible matrices |
| 09/18/1996 | EP0575461B1 Fat compositions and their use in cosmetic and pharmaceutical emulsion products |
| 09/18/1996 | EP0571414B1 Novel complexes containing nucleic acid which can be absorbed into higher eucaryotic cells via endocytosis |
| 09/18/1996 | EP0511991B1 Pharmaceutical formulation containing penciclovir |
| 09/18/1996 | CN1131042A Biodegradable sustained release preparation for treating periodontitis |
| 09/18/1996 | CN1131041A Soft gelatin pharmaceutical dosage form |
| 09/17/1996 | US5556982 Metal radionuclide labeled proteins for diagnosis and therapy |
| 09/17/1996 | US5556948 Phospholipid derivatized with PEG bifunctional linker and liposome containing it |
| 09/17/1996 | US5556882 Methods of treating wrinkles using benzilic acid |
| 09/17/1996 | US5556642 Method for producing sustained release microsphere preparation |
| 09/17/1996 | US5556641 Light stable color compositions |
| 09/17/1996 | US5556640 Dry gel composition |
| 09/17/1996 | US5556639 Lamotrigine anticonvulsant |
| 09/17/1996 | US5556638 Flurbiprofen-containing immediate-effect medicament and its use |
| 09/17/1996 | US5556636 Silicon modified polyoxyalkylene polymer, transdermal drug delivery |
| 09/17/1996 | US5556623 Inhibiting neoplasm growth in mammal by parenterally administering immunoconjugate of antibody or antigen-binding fragment thereof with beta-alanine whose amino is converted to drug derivative-substituted methylene amide |
| 09/17/1996 | US5556611 Preventing and treating mucosal diseases of epithelia of tracheobronchial tract by topically applying aerosol inhalate comprising ester of retinoic acid or ester of retinol; particles of specified size |
| 09/17/1996 | CA2165727A1 Affinity bound collagen matrices for the delivery of biologically active agents |
| 09/17/1996 | CA2019466C Minerals in bioavailable form |
| 09/17/1996 | CA1338595C Gelled emulsion particles and compositions in which they are present |
| 09/16/1996 | CA2171881A1 Single-shot vaccine formulation |
| 09/12/1996 | WO1996027662A1 Novel encapsulation process by a gelling polymer |
| 09/12/1996 | WO1996027608A1 Process for producing a protein |
| 09/12/1996 | WO1996027376A1 Corticosteroid-containing pharmaceutical composition |
| 09/12/1996 | WO1996027372A1 Water-based topical cream containing nitroglycerin; method of preparation and use thereof |
| 09/12/1996 | WO1996027368A1 Liquid aqueous pharmaceutical compositions comprising sodium alginate and potassium bicarbonate |
| 09/12/1996 | WO1996027367A1 Novel encapsulation compositions and methods |
| 09/12/1996 | WO1996027366A1 Cosmetic and/or pharmaceutical preparations |
| 09/12/1996 | WO1996027346A1 Controlled dissolution pellet containing calcium sulfate |
| 09/12/1996 | WO1996021468A3 Chemically modified interferon |
| 09/12/1996 | WO1996003502A3 Muc1 derived proteins for the diagnosis, imaging and therapy of human cancer |
| 09/12/1996 | DE19507531A1 Kosmetische und/oder pharmazeutische Zubereitungen Cosmetic and / or pharmaceutical preparations |
| 09/12/1996 | CA2214088A1 Novel encapsulation process by a gelling polymer |
| 09/12/1996 | CA2214084A1 Novel encapsulation compositions and methods |